Biomark Diagnostics Inc. (FRA:20B)
0.2000
+0.0010 (0.50%)
At close: Nov 27, 2025
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of €23.33 million as of December 1, 2025. Its market cap has increased by 97.46% in one year.
Market Cap
23.33M
Enterprise Value
22.87M
Revenue
75.52K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.20
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has decreased from 28.50M to 23.33M, a decrease of -18.13%. That is a compound annual growth rate of -1.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 20.70M | 108.98% |
| Dec 30, 2024 | 9.91M | -19.08% |
| Dec 29, 2023 | 12.24M | 23.53% |
| Dec 30, 2022 | 9.91M | -23.89% |
| Dec 30, 2021 | 13.02M | 134.71% |
| Dec 30, 2020 | 5.55M | -54.32% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |